Shopping Cart 0
Cart Subtotal
USD 0

Medigen Biotechnology Corp (3176)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Medigen Biotechnology Corp (MBC) is a pharmaceutical company that carries out the research and development of biopharmaceuticals for the treatment of liver diseases and cancers. It focuses at developing new therapeutics, principally in the area of cancer and liver diseases. The company's product portfolio includes monoclonal antibodies; vaccines; molecular diagnostics and generic drugs. MBC also provides original equipment manufacturing (OEM) and original design manufacturing (ODM) manufacturing services in various dosage forms including orals, externals, ophthalmic and hormones; nutrition supplements; cosmeceutical products. 's subsidiaries include Medigen Vaccine Biologics; TBG Biotechnology Corp.; and Winston Medical Supply Co., Ltd. MBC is headquartered in Taipei city, Taiwan.

Medigen Biotechnology Corp (3176)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Medigen Biotechnology Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Medigen Biotechnology Corp, Medical Devices Deals, 2011 to YTD 2017 9

Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deal Details 12

Asset Purchase 12

Medigen Biotech Acquires B-cell Immortalization Platform Technology 12

Partnerships 12

Medigen Biotech to Form Joint Venture for Vaccine Technology 12

Licensing Agreements 13

Medigen Vaccine Biologics Enters into Licensing Agreement with National Institutes of Health for Dengue Vaccine 13

Progen Pharma To Enter Into Licensing Agreement With Medigen Biotech For PG545 13

Equity Offering 15

Medigen Vaccine Biologics to Raise Up to USD15.8 Million in Private Placement of Shares 15

Medigen Vaccine Biologics to Raise up to USD13.5 Million in Private Placement of Shares 15

Medigen Vaccine Biologics Raises USD13.5 Million in Rights Offering of Shares 16

Medigen Biotech to Raise Funds in Public Offering of Shares 17

Medigen Vaccine Biologics Raises USD28.8 Million in IPO 17

Medigen Biotech Completes Public Offering Of Shares For US$4 Million 18

Medigen Biotech Completes Rights Offering Of Shares For US$32 Million 19

Medigen Biotech Announces Rights Offering Of Shares For US$21 Million 20

Medigen Biotech Announces Public Offering Of Shares For US$2.7 Million 20

Medigen Biotech Prices Public Offering Of Common Stock For US$10 Million 21

Acquisition 22

United Microelectronics Acquires 8% Stake in Medigen for USD4 Million 22

Medigen Biotech To Acquire 67.92% Stake In Winston Medical 23

PerkinElmer Acquires Shanghai Haoyuan Biotech From Medigen Biotech For US$38 Million 23

Medigen Biotech Acquires Remaining Stake In Texas BioGene 25

Medigen Biotechnology Corp-Key Competitors 26

Key Employees 27

Locations And Subsidiaries 28

Head Office 28

Other Locations & Subsidiaries 28

Appendix 29

Methodology 29

About GlobalData 29

Contact Us 29

Disclaimer 29


List Of Figure

List of Figures

Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Medigen Biotechnology Corp, Medical Devices Deals, 2011 to YTD 2017 9


List Of Table

List of Tables

Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Key Facts, 2015 1

Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Medigen Biotechnology Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Medigen Biotechnology Corp, Deals By Therapy Area, 2011 to YTD 2017 8

Medigen Biotechnology Corp, Medical Devices Deals, 2011 to YTD 2017 9

Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Medigen Biotech Acquires B-cell Immortalization Platform Technology 12

Medigen Biotech to Form Joint Venture for Vaccine Technology 12

Medigen Vaccine Biologics Enters into Licensing Agreement with National Institutes of Health for Dengue Vaccine 13

Progen Pharma To Enter Into Licensing Agreement With Medigen Biotech For PG545 13

Medigen Vaccine Biologics to Raise Up to USD15.8 Million in Private Placement of Shares 15

Medigen Vaccine Biologics to Raise up to USD13.5 Million in Private Placement of Shares 15

Medigen Vaccine Biologics Raises USD13.5 Million in Rights Offering of Shares 16

Medigen Biotech to Raise Funds in Public Offering of Shares 17

Medigen Vaccine Biologics Raises USD28.8 Million in IPO 17

Medigen Biotech Completes Public Offering Of Shares For US$4 Million 18

Medigen Biotech Completes Rights Offering Of Shares For US$32 Million 19

Medigen Biotech Announces Rights Offering Of Shares For US$21 Million 20

Medigen Biotech Announces Public Offering Of Shares For US$2.7 Million 20

Medigen Biotech Prices Public Offering Of Common Stock For US$10 Million 21

United Microelectronics Acquires 8% Stake in Medigen for USD4 Million 22

Medigen Biotech To Acquire 67.92% Stake In Winston Medical 23

PerkinElmer Acquires Shanghai Haoyuan Biotech From Medigen Biotech For US$38 Million 23

Medigen Biotech Acquires Remaining Stake In Texas BioGene 25

Medigen Biotechnology Corp, Key Competitors 26

Medigen Biotechnology Corp, Key Employees 27

Medigen Biotechnology Corp, Other Locations 28

Medigen Biotechnology Corp, Subsidiaries 28

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Medigen Biotechnology Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.